Vineet Laboratories Q4FY26 Results: Net profit turns positive at ₹72.5 lakh
- Net profit for Q4FY26 was ₹72.51 lakh, reversing a loss of ₹1,052.51 lakh in Q4FY25
- Full year net profit stood at ₹111.08 lakh against a loss of ₹2,019.10 lakh in FY25
- Revenue from operations for Q4FY26 rose to ₹1,889.14 lakh from ₹1,407.65 lakh YoY
- Other expenses dropped significantly to ₹821.77 lakh in FY26 from ₹1,570.39 lakh in FY25
- Outstanding long-term borrowings reduced to ₹35.29 crore from ₹39.09 crore
*this image is generated using AI for illustrative purposes only.
The Board of Directors of Vineet Laboratories approved audited standalone financial results for the fourth quarter and fiscal year ended March 31, 2026, on August 25, 2026.
The company reported a net profit of ₹72.51 lakh for Q4FY26, a significant turnaround from the net loss of ₹1,052.51 lakh recorded in the same quarter last year. For the full fiscal year, Vineet Laboratories posted a net profit of ₹111.08 lakh, reversing a net loss of ₹2,019.10 lakh in FY25.
Financial Performance
Revenue from operations for Q4FY26 stood at ₹1,889.14 lakh, up from ₹1,407.65 lakh in Q4FY25. However, total revenue for FY26 declined to ₹5,940.10 lakh from ₹7,499.50 lakh in the previous year.
| Metric | Q4FY26 | Q4FY25 | FY26 | FY25 |
|---|---|---|---|---|
| Revenue from operations (₹ lakh) | 1,889.14 | 1,407.65 | 5,940.10 | 7,499.50 |
| Net Profit/(Loss) (₹ lakh) | 72.51 | (1,052.51) | 111.08 | (2,019.10) |
Profit before tax for the quarter was ₹99.46 lakh compared to a loss of ₹1,122.13 lakh in Q4FY25. For the full year, profit before tax was ₹128.27 lakh against a loss of ₹2,077.55 lakh in FY25.
What the Numbers Show
A key driver behind the improved profitability in FY26 was a substantial reduction in other expenses. Other expenses fell to ₹821.77 lakh in FY26 from ₹1,570.39 lakh in FY25. This decline occurred alongside a decrease in cost of materials consumed, which dropped to ₹6,188.34 lakh from ₹6,376.84 lakh in the prior year, helping offset lower revenue.
Balance Sheet and Borrowings
As of March 31, 2026, total assets stood at ₹12,478.34 lakh, up from ₹9,454.01 lakh in the previous year. Current assets increased significantly to ₹9,882.92 lakh from ₹6,739.38 lakh, driven by higher inventories of ₹6,409.07 lakh and cash and cash equivalents of ₹1,669.52 lakh.
Outstanding long-term borrowings decreased to ₹35.29 crore at the end of FY26 from ₹39.09 crore at the start of the year. The company confirmed it did not undertake any incremental qualified borrowings or issue debt securities during the year.
Auditor Opinion
Statutory Auditors NSVR & Associates LLP issued an unmodified opinion on the standalone financial results for the year ended March 31, 2026.
Historical Stock Returns for Vineet Laboratories
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +3.56% | +3.59% | +0.47% | +27.93% | +11.95% | -38.03% |
How does the significant year-over-year decline in total revenue for FY26 impact Vineet Laboratories' long-term growth trajectory despite the return to profitability?
What specific strategic initiatives drove the substantial reduction in other expenses, and are these cost-cutting measures sustainable for future quarters?
Given the increase in current assets driven by higher inventories, what is the company's plan to ensure efficient inventory turnover and avoid potential write-downs?
16
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
